Vestal Point Capital »

Ptc Therapeutics I shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 90k 30.58

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Ptc Therapeutics I

Vanguard Group
Wellington Management Company
BlackRock
Rtw Investments
Armistice Capital
Camber Capital Management
Cowen And Company
Henderson Group
State Street Corporation
Geode Capital Management
FMR
Jacobs Levy Equity Management
Morgan Stanley
Franklin Resources
First Trust Advisors

View all funds holding Ptc Therapeutics I